Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7952 results

Sort By:

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children with Generalized Myasthenia Gravis

Study ID: NCT04833894
Start Date: 2021-10-26
End Date: 2027-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

12

Intervention / Treatment

Efgartigimod IV

Sponsor

argenx

Source: clinicaltrials.gov

Share:
Add to list

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

Study ID: NCT03471260
Start Date: 2018-03-19
End Date: 2025-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

96

Intervention / Treatment

Azacitidine

Ivosdenib

Venetoclax

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors

Study ID: NCT06082960
Start Date: 2023-10-09
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase1

No. of Participants

120

Intervention / Treatment

GS-9911

Zimberelimab

Sponsor

Gilead Sciences

Source: clinicaltrials.gov

Share:
Add to list

Repositioning Immunotherapy in VetArans With Lung Cancer

Study ID: NCT06275360
Start Date: 2024-03-01
End Date: 2030-03-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

Nivolumab

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

International Rare Histiocytic Disorders Registry (IRHDR)

Study ID: NCT02285582
Start Date: 2014-10
End Date: 2028-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Registry study

Sponsor

The Hospital for Sick Children

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Study ID: NCT05803382
Start Date: 2023-11-08
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Bet Bromodomain Inhibitor Zen-3694

Biopsy Procedure

Biospecimen Collection

Capecitabine

Computed Tomography

Magnetic Resonance Imaging

Positron Emission Tomography

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

Study ID: NCT03127631
Start Date: 2015-10-21
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

6000

Intervention / Treatment

Nutrition

Exercise

Smoking cessation

Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin)

ACE inhibitor

Sponsor

McMaster University

Source: clinicaltrials.gov

Share:
Add to list

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Study ID: NCT06289673
Start Date: 2024-12-26
End Date: 2039-05
Study Type

Interventional

Study Phase

Phase4

No. of Participants

850

Intervention / Treatment

Dexamethasone

Vincristine

Etrorior

Intrathecal triple therapy (methotrexate + hydrocortisone + cytarabine)

Methotrexate

Cytarabine

Sponsor

St. Jude Children's Research Hospital

Source: clinicaltrials.gov

Share:
Add to list

Clinical Orthopaedic Data Bank (Acute and Chronic)

Study ID: NCT00411060
Start Date: 2007-01
End Date: 2025-07-14
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10000

Intervention / Treatment
Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

Ladarixin With Sotorasib in Advanced NSCLC

Study ID: NCT05815173
Start Date: 2023-08-01
End Date: 2026-08
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

Selling

Ladarixin

Sponsor

NYU Langone Health

Source: clinicaltrials.gov

Share:
Add to list